M. Vilien
Impact in
- Genetics top 1%
- Inflammatory Bowel Disease
- Gastroenterology top 2%
- Gastroesophageal reflux and treatments
Papers in
- Co-authors
- Per M. Hellström (4 shared papers)Christer Grännö (4 shared papers)Erik Hertervig (4 shared papers)Anders Magnuson (4 shared papers)Per Karlén (4 shared papers)Ingalill Friis–Liby (3 shared papers)Hans Verbaan (4 shared papers)Gunnar Järnerot (2 shared papers)
In The Last Decade
M. Vilien
35 papers receiving 1.9k citations
M. Vilien's Hit Papers
Peers
Comparison fields: 5 of 84
- Genetics 1.2k
- Gastroenterology 188
- Epidemiology 651
- Immunology 248
- Surgery 448
Countries citing papers authored by M. Vilien
This map shows the geographic impact of M. Vilien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Vilien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Vilien more than expected).
Fields of papers citing papers by M. Vilien
This network shows the impact of papers produced by M. Vilien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Vilien. The network helps show where M. Vilien may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Vilien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study Hit paper breakdown → | 2005 | 812 |
| 2 | 2015 | 146 | |
| 3 | 1992 | 145 | |
| 4 | 2010 | 137 | |
| 5 | 1987 | 102 | |
| 6 | 2016 | 83 | |
| 7 | 2004 | 57 | |
| 8 | A classification of human urothelial cells propagated in vitro. | 1985 | 49 |
| 9 | 2002 | 42 | |
| 10 | 1983 | 35 | |
| 11 | 1992 | 31 | |
| 12 | 1978 | 30 | |
| 13 | [Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo]. | 1988 | 28 |
| 14 | 1980 | 25 | |
| 15 | 1997 | 23 | |
| 16 | 1990 | 23 | |
| 17 | 1992 | 22 | |
| 18 | 1973 | 21 | |
| 19 | 1981 | 17 | |
| 20 | A 2-year follow-up of the swedish-danish Infliximab/Placebo trial in steroid resistant acute ulcerative colitis | 2007 | 14 |
About M. Vilien
M. Vilien is a scholar working on Genetics, Surgery, Epidemiology, Gastroenterology and Oncology, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (8 papers), Immunotherapy and Immune Responses (5 papers), Gastroesophageal reflux and treatments (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Tissue Engineering and Regenerative Medicine (4 papers), Immune cells in cancer (3 papers) and Liver Diseases and Immunity (3 papers). The work is most often cited by research in Genetics (1.2k citations), Gastroenterology (188 citations), Epidemiology (651 citations), Immunology (248 citations) and Surgery (448 citations). M. Vilien has collaborated with scholars based in Denmark, Sweden and Norway. Frequent co-authors include Per M. Hellström, Christer Grännö, Erik Hertervig, Anders Magnuson, Per Karlén, Ingalill Friis–Liby, Hans Verbaan, Gunnar Järnerot, Magnus Ström and Lars Blomquist. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Gut, Alimentary Pharmacology & Therapeutics, Gastroenterology and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.